BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1033604)

  • 1. Suppression by 1,3-butanediol of the ethanol withdrawal syndrome in rats.
    Majchrowicz E; Hunt WA; Piantadosi C
    Science; 1976 Dec; 194(4270):1181-2. PubMed ID: 1033604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of an ethanol withdrawal syndrome in rats by butyrate, lactate and beta-hydroxybutyrate.
    Derr RF; Draves K; Derr M
    Life Sci; 1983 May; 32(22):2551-4. PubMed ID: 6682922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats.
    Fadda F; Colombo G; Mosca E; Gessa GL
    Alcohol Alcohol; 1989; 24(5):447-51. PubMed ID: 2818752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of an ethanol withdrawal syndrome in rats by 3-hydroxybutyrate.
    Derr RF; Derr M
    Life Sci; 1985 Feb; 36(8):763-7. PubMed ID: 4038774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression by progabide of ethanol withdrawal syndrome in rats.
    Fadda F; Mosca E; Meloni R; Gessa GL
    Eur J Pharmacol; 1985 Mar; 109(3):321-5. PubMed ID: 2985405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol.
    Frye GD; Chapin RE; Vogel RA; Mailman RB; Kilts CD; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1981 Feb; 216(2):306-14. PubMed ID: 7193248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated blood ketone and glucagon levels cannot account for 1,3-butanediol induced cerebral protection in the Levine rat.
    Lundy EF; Klima LD; Huber TS; Zelenock GB; D'Alecy LG
    Stroke; 1987; 18(1):217-22. PubMed ID: 3810756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between 1,4-butanediol and ethanol on operant responding and the cardiovascular system.
    Gerak LR; Hicks AR; Winsauer PJ; Varner KJ
    Eur J Pharmacol; 2004 Dec; 506(1):75-82. PubMed ID: 15588627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxic role of an endogenous substance: 1,4-butanediol].
    Poldrugo F
    Minerva Psichiatr; 1984; 25(1):55-60. PubMed ID: 6377001
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethanol potentiates the toxic effects of 1,4-butanediol.
    Poldrugo F; Barker S; Basa M; Mallardi F; Snead OC
    Alcohol Clin Exp Res; 1985 Dec; 9(6):493-7. PubMed ID: 3911807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Chloro-N6-cyclopentyladenosine (CCPA), an adenosine A1 receptor agonist, suppresses ethanol withdrawal syndrome in rats.
    Concas A; Cuccheddu T; Floris S; Mascia MP; Biggio G
    Alcohol Alcohol; 1994 May; 29(3):261-4. PubMed ID: 7945566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
    Wood DM; Brailsford AD; Dargan PI
    Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats.
    Uzbay T; Kayir H; Celik T; Yüksel N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):478-85. PubMed ID: 16412550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metabolite concentrations and redox states in rats fed diets containing 1,3-butanediol and ethanol.
    Veech RL; Harris RL; Mehlman MA
    Toxicol Appl Pharmacol; 1974 Aug; 29(2):196-203. PubMed ID: 4283684
    [No Abstract]   [Full Text] [Related]  

  • 16. Administration of low doses of MK-801 during ethanol withdrawal in the developing rat pup attenuates alcohol's teratogenic effects.
    Thomas JD; Fleming SL; Riley EP
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1307-13. PubMed ID: 12198409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats.
    Colombo G; Agabio R; Lobina C; Reali R; Melis F; Fadda F; Gessa GL
    Alcohol Alcohol; 1995 Jan; 30(1):125-31. PubMed ID: 7748269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of acetaldehyde and 2,3-butanediol on rat embryos developing in vitro.
    Priscott PK
    Biochem Pharmacol; 1985 Feb; 34(4):529-32. PubMed ID: 3970722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lorazepam treatment for multiple ethanol withdrawals in mice.
    Becker HC; Veatch LM
    Alcohol Clin Exp Res; 2002 Mar; 26(3):371-80. PubMed ID: 11923591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of escitalopram on ethanol withdrawal syndrome in rats.
    Sağlam E; Kayir H; Celik T; Uzbay T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1027-32. PubMed ID: 16650516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.